Palisade Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-13,950
Closed -$967K – 530
2015
Q1
$967K Sell
13,950
-10,962
-44% -$758K 0.02% 401
2014
Q4
$1.72M Sell
24,912
-9,063
-27% -$612K 0.04% 343
2014
Q3
$2.22M Buy
33,975
+6,540
+24% +$431K 0.06% 331
2014
Q2
$1.87M Sell
27,435
-21,285
-44% -$1.43M 0.05% 329
2014
Q1
$3.16M Sell
48,720
-395
-0.8% -$24.9K 0.08% 289
2013
Q4
$3.2M Buy
49,115
+4,600
+10% +$294K 0.08% 288
2013
Q3
$2.64M Buy
44,515
+38,300
+616% +$2.27M 0.07% 297
2013
Q2
$356K Buy
+6,215
New +$369K 0.01% 384

Other funds holding CL

Palisade Capital Management's CL Position: Q2 2015 in Review

Palisade Capital Management sold out of Colgate-Palmolive (CL) in Q2 2015, closing a stake of 13,950 shares — an estimated $967K sold.

Palisade Capital Management first reported a position in CL in Q2 2013 and held it in 8 quarters. The position peaked at $3.2M in Q4 2013. 1,234 funds tracked by Wall St. Rank hold CL as of Q2 2015.

  • Palisade Capital Management reported no remaining Colgate-Palmolive position as of Q2 2015 after selling out during the quarter.
  • Palisade Capital Management sold 13,950 Colgate-Palmolive shares in Q2 2015, an estimated $967K.
  • Palisade Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and held it in 8 quarters.
  • Palisade Capital Management's Colgate-Palmolive position peaked at $3.2M in Q4 2013.
  • 1,234 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2015.

Based on Palisade Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.